SparingVision
Manufacturing · France · 11-50 Employees
View Company Info for Free
Overview
Headquarters
5-7 Ave Percier Cs40230, Paris, Ile-de-F...Phone Number
+33 143462060Website
www.sparingvision.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
1
1
1
1
1
About SparingVision
SparingVision is a genomic medicines company, translating pioneering science into vision-saving treatments.Explore more
SparingVision Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is SparingVision your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when SparingVision launches new products
Congratulate Masked Content for being promoted to Masked Content at SparingVision
Check if SparingVision has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
SparingVision, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on SparingVision recently announced quarterly report
Click to see if SparingVision had a recent Job posting/layoffs
Check out if SparingVision is spiking on competitors!
Funding: Get notified immidiatlly once SparingVision has new funding data
Recommended Actions
Find VP level buyers at SparingVision
Find 2 more new buyers
Company Profile Activity
Activity Insights
SparingVision is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
SparingVision is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about SparingVision.
SparingVision financials insights
Gather financial insights about SparingVision, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2019
Grant
$2.8M
2020
Series A
$52.7M
2022
Series B
$75M
SparingVision Tech Stack
A closer look at the technologies used by SparingVision
See more technologies
Most Recent Scoops
Project
Laboratory Operations, Medical Research, Clinical Operations
Left Company
Executive Move
Executive Moves, Left Company
Event
Person-Based
Events, Search, Medical Research
Award
Award, Engineering, Product Development, Research & Development
Executive Move
Board of Directors
SparingVision News & Media
SparingVision Reaches Final Dose Escalation Step in PRODYGY Trial with SPVN06 for retinitis pigmentosa
SparingVision Reaches Final Dose Escalation Step in PRODYGY Trial with SPVN06 for retinitis pigmentosaSparingVision Reports Positive Initial Safety Data from the first cohort treated in its PRODYGY Phase I/II Gene Therapy Trial
SparingVision Reports Positive Initial Safety Data from the first cohort treated in its PRODYGY Phase I/II Gene Therapy TrialSparingVision sells ex vivo GIRK technology to Tenpoint Therapeutics
SparingVision sells ex vivo GIRK technology to Tenpoint Therapeutics
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding SparingVision
Sign Up For FreeTo access detailed company insights
SparingVision is a genomic medicines company, translating pioneering science into vision-saving treatments.... Read More
